NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
    India

    SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally

    SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
    Written by Siddhant Pandey
    Jan 05, 2021, 05:00 pm 3 min read
    SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally

    The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them. SII's Covishield and Bharat Biotech's COVAXIN had been granted emergency use authorization (EUA) for restricted use in India earlier on Sunday. On Monday, Prime Minister Narendra Modi said that India will soon start its vaccination drive.

    'Fully aware of importance of vaccines for people and countries'

    According to a statement, both SII CEO Adar Poonawalla and Bharat Biotech MD Krishna Ella communicated their intent to "develop, manufacture, and supply the COVID-19 vaccines for India and globally." "We are fully aware of the importance of vaccines for people and countries alike. We hereby communicate our joint pledge to provide global access for our COVID-19 vaccines," the statement added.

    Companies to prioritize populations that need vaccine most

    The statement mentioned that the two companies are now focusing on the manufacture, supply, and distribution of the vaccines in a way that prioritizes populations that need them most. "Both our companies are fully engaged in this activity and consider it our duty to the nation and the world at large to ensure a smooth rollout of vaccines," it said.

    How were the vaccines made?

    Covishield—developed by AstraZeneca and Oxford University and manufactured by SII—is a recombinant chimpanzee adenovirus vector vaccine encoding the SARS-CoV-2 spike protein. It has been found to have an overall efficacy of 70.42%. COVAXIN is an inactivated vaccine, i.e., it uses a killed version of the whole virus. Phase III trials are still underway, hence, Bharat Biotech is yet to submit efficacy data.

    Both vaccines granted EUA on Sunday

    On Sunday, the Drugs Controller General of India (DCGI) Dr. VG Somani had announced that the two vaccines have been granted EUA. The emergency approval for COVAXIN has drawn criticism from independent experts due to the language used. The vaccine has been granted EUA "in public interest as an abundant precaution, in clinical trial mode, especially in the context of infection by mutant strains."

    COVAXIN to be used as back-up, say AIIMS, ICMR heads

    The language used for the EUA for COVAXIN has led many to believe that the vaccine has only been granted approval to be used as a "back-up," unlike SII's Covishield. The same was confirmed by members of the National COVID-19 Task Force—AIIMS Director Dr. Randeep Guleria and ICMR Director-General Dr. Balram Bhargava—who told The Indian Express that COVAXIN will be used as a back-up.

    COVAXIN not a back-up, says Bharat Biotech MD

    However, Ella has disputed the statement of the heads of AIIMS and ICMR regarding the vaccine being used as a back-up. He has also said that Bharat Biotech has "tremendous experience" in developing vaccines and their vaccine is "200% safe."

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Narendra Modi
    All India Institute Of Medical Sciences (AIIMS)
    Oxford University
    Randeep Guleria

    Latest

    #NewsBytesExplainer: How does repo rate affect the common man Reserve Bank Of India (RBI)
    World Test Championship 2021-2023 final to start from June 7 ICC World Test Championship
    Mahua Moitra uses cuss word in Parliament, defends it later Mahua Moitra
    Osteoporosis: Causes, symptoms, prevention, and treatment Health & Wellness

    Narendra Modi

    Adani-Hindenburg row: BJP MP seeks moving privilege motion against Gandhi Congress Party
    What's Adani's relation with PM Modi: Rahul Gandhi in Parliament Rahul Gandhi
    India sends first batch of relief aid to earthquake-hit Turkey India
    Adani-Hindenburg row: Opposition stalls Parliament proceedings, seeks PM Modi's response Parliament

    All India Institute Of Medical Sciences (AIIMS)

    Shraddha Walkar murder: Police's 3000-draft chargesheet ready, legal approval awaited Shraddha Walkar
    Man throws 2-year-old son from balcony after fight with wife Delhi
    Delhi AIIMS cyberattack originated in China, servers retrieved: Sources Delhi
    Tamil Nadu hospital suffers cyber attack; patient data sold online Cybercrimes

    Oxford University

    Cambridge Dictionary alters 'man' and 'woman' definitions, faces criticism Social Media
    COVID-19 vaccine maker Professor Sarah Gilbert honored with Barbie doll Coronavirus
    AstraZeneca vaccine's single dose reduces death risk by 80%: Data Pfizer
    #OxfordUniversity racism row: India to raise the issue when required S Jaishankar

    Randeep Guleria

    Dr. Randeep Guleria's 30-year-long AIIMS journey ends with voluntary retirement All India Institute Of Medical Sciences (AIIMS)
    AIIMS Delhi nurses' union launches indefinite strike today: Details here All India Institute Of Medical Sciences (AIIMS)
    COVID-19 vaccines for children likely by September, says AIIMS chief Zydus Cadila
    When can your kid return to school? AIIMS chief answers India

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023